BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200928
DTEND;VALUE=DATE:20200930
DTSTAMP:20260515T113629
CREATED:20200217T113517Z
LAST-MODIFIED:20200817T084802Z
UID:24213-1601251200-1601423999@www.pharmajournalist.com
SUMMARY:2nd European Protein Degradation Congress
DESCRIPTION:With deals in the protein degradation market reaching nearly $2 billion and unique degradation ideas coming into play such as LYTACs and ENDTACs\, eyes are focused on how much further protein degradation-based therapeutics will continue to grow within the pharmaceutical industry. \nFollowing huge success in May 2019\, the 2nd European Protein Degradation Congress\, returns on 28th – 29th September 2020\, where you can hear the most up to date and relevant information for the broad range of topics in the field of targeted protein degradation. \n \nNew areas will cover novel methods in harnessing E3 ligases and the latest discoveries from PROTACs and molecular glues with preclinical and clinical data being shown. \nLeading industry players from biotechs and big pharma will come together to exchange thoughts on how to best overcome obstacles to achieving reliable in vitro and in vivo data. Academic experts will be present their latest research to help build a deeper understanding of the mechanisms involved in the Ubiquitin pathway\, providing a clearer picture on what makes a good\, or not good\, target for degradation. \nTo know more about 2nd European Protein Degradation Congress please click here.
URL:https://www.pharmajournalist.com/event/2nd-european-protein-degradation-congress/
LOCATION:Virtual Event
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR